News

Find News

Filter articles

Applied Filters

Showing 821 to 830 of 895 results

Generic KRKA to receive damages in Nexium case

UK28-01-2014Legal developments

The UK High Court has decided to award Slovenian generic pharmaceutical company KRKA damages after a preliminary injunction enforced against the company by AstraZeneca was discharged.

India considers more compulsory licences

India24-01-2014

A government-appointed panel in India is preparing to evaluate more patented drugs for local generic pharmaceutical companies to mimic, according to reports.

Novo Nordisk leaves alliance over PR campaign

South Africa23-01-2014

Pharmaceutical company Novo Nordisk has left a group of pharmaceutical companies that are unhappy with proposed drug laws in South Africa.

Actavis survives challenge to birth control pill

US21-01-2014Legal developments

On January 17, Actavis confirmed that the US District Court for the District of New Jersey found its US patent 7,704,984, which covers Lo Loestrin Fe birth control pills, to be valid and infringed by Lupin and Amneal.

Aurobindo to acquire Actavis’s European generic units

EU, India20-01-2014Mergers & acquisitions

Aurobindo’s European subsidiary is set to acquire Actavis’s commercial generic operations in seven Western European markets in a deal worth about €30 million ($40 million).

South African PR efforts spark drug controversy

South Africa17-01-2014

South African drug companies have been accused by advocacy organisations of planning a "deceptive" campaign to delay new laws which could see the introduction of more generic medicines.

Court says Teva not infringing OxyContin patents

US15-01-2014

A US judge has said Teva Pharmaceuticals did not infringe patents belonging to a rival company after seeking approval to market a generic version of the drug.

EIP hires Teva litigator

UK07-01-2014

EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.

Pfizer allows Teva’s generic Viagra

US19-12-2013Legal developments

Viagra-maker Pfizer Ltd and Teva Pharmaceutical Industries have agreed to settle patent litigation related to Teva’s generic version of Viagra (sildenafil citrate) tablets.

FDA approves first generic versions of Lilly’s $5bn Cymbalta

US16-12-2013

The US Food and Drug Administration (FDA) has approved the first generic versions of antidepressant drug Cymbalta (duloxetine hydrochloride), after Eli Lilly’s primary patent covering the product expired on December 11.

Showing 821 to 830 of 895 results

LSIPR